2012-01-30 - Female - 38 Years old
405598
| Adverse reaction report number | 405598 |
| Latest AER version number | 0 |
| Market authorization holder AER number | ALL1201301041 |
| Initial received date | 2012-01-30 |
| Latest received date | 2012-01-30 |
| Age | 38 Years |
| Gender | Female |
| Weight | 128 Pounds |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | Community |
| Report outcome | Recovered/resolved |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | Suspect | Oral | 5 Milligram | 1 every 1 Day(s) | 1 Month(s) | Product used for unknown indication | |
| ADDERALL XR | Suspect | Oral | 10 Milligram | 1 every 1 Day(s) | Product used for unknown indication | ||
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 5 Milligram | 1 every 1 Day(s) | 1 Week(s) | Product used for unknown indication |
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 10 Milligram | 1 every 1 Day(s) | Product used for unknown indication | |
| CELEXA | TABLET | Concomitant | |||||
| SYNTHROID | NOT SPECIFIED | Concomitant |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Anxiety | |
| Decreased appetite | |
| Fatigue | |
| Insomnia | |
| Loss of consciousness | |
| Palpitations | |
| Psychomotor hyperactivity | |
| Tachycardia | |
| Tremor | |
| Weight decreased | |